Does Humana Cover Depression Treatment in Delaware? A 2026 Guide

Last updated: July 24, 2026

If you have a Humana plan in Delaware and need depression treatment, the first thing to understand is that Humana operates in Delaware exclusively as a Medicare Advantage (MAPD) plan. There are no Humana commercial or Marketplace plans available in Delaware. That distinction shapes everything about how your coverage works. From the governing federal framework to the appeal process when a claim is denied.

This guide explains how Humana Medicare Advantage covers depression treatment in Delaware in 2026, which antidepressants may be on the Humana Pharmacy Solutions (HPS) formulary, how Delaware’s electronic prescribing law applies, and what steps to take if coverage is denied.

Key Facts. Humana Depression Coverage in Delaware (2026)

• Plan type: Medicare Advantage (MAPD) only. No Humana commercial plans in Delaware
• PBM: Humana Pharmacy Solutions (HPS)
• Governing framework: CMS 42 CFR Part 422. Not Delaware state insurance law
• State parity law: Del. Code Ann. tit. 18, § 3343 is preempted by federal Medicare Advantage law for MAPD plans
• EPCS. Standard antidepressants: SSRIs, SNRIs, bupropion, mirtazapine, TCAs, Trintellix, Auvelity. All non-scheduled. Delaware EPCS law is entirely inapplicable
• EPCS. Spravato (esketamine): Schedule III controlled substance. EPCS REQUIRED in Delaware. Also requires REMS enrollment and treatment-resistant depression (TRD) documentation (2+ failed antidepressant trials)
• Medicaid/dual-eligible: If you also have Medicaid (dual-eligible), Humana D-SNP may apply. See below
• Federal appeal: Humana redetermination → Maximus IRE 1-855-887-6668 → Administrative Law Judge → MAC → federal court
• Key contacts: Humana 1-800-448-6262 / HPS 1-800-379-0092 / Delaware DOI 1-302-674-7300 / Delaware SHIP 1-800-336-9500 / CMS 1-800-633-4227

See if you may qualify for depression treatment through Klarity Health. Verify your benefits today

Humana Medicare Advantage in Delaware: What Governs Your Depression Coverage

Medicare Advantage plans like Humana MAPD are governed by federal law. Specifically CMS regulations under 42 CFR Part 422. Not by Delaware state insurance statutes. This is a critical distinction for depression treatment.

Delaware’s mental health parity law (Del. Code Ann. tit. 18, § 3343) does apply to fully insured commercial plans, but it does not govern Medicare Advantage plans. For MAPD members, parity protections come from the federal Mental Health Parity and Addiction Equity Act (MHPAEA) as implemented through CMS. If you believe Humana is applying more restrictive coverage limitations to depression treatment than to comparable medical/surgical conditions, your complaint pathway is CMS. Not the Delaware Department of Insurance.

That said, CMS does require MHPAEA compliance from all Medicare Advantage plans, meaning Humana MAPD must cover mental health services. Including depression treatment. On par with medical/surgical benefits.

What Is the Humana Pharmacy Solutions (HPS) Formulary for Depression Medications?

Humana Medicare Advantage Part D drug coverage is administered by HPS. The following table reflects how depression medications are typically structured on HPS formularies. Exact tier placement and prior authorization requirements vary by specific plan. Always verify your plan’s Evidence of Coverage (EOC) or call HPS at 1-800-379-0092.

Delaware EPCS Law and Depression Medications

Delaware’s Electronic Prescribing for Controlled Substances (EPCS) law (DE Admin Code Title 24 § 1700) requires that controlled substances be prescribed electronically. The law applies to Schedule II through Schedule V substances.

The critical point for most depression patients: nearly all commonly prescribed antidepressants are not controlled substances. SSRIs, SNRIs, bupropion, mirtazapine, Trintellix, and Auvelity are all non-scheduled medications. Delaware’s EPCS law is entirely inapplicable to these drugs, meaning there is no electronic prescribing barrier for telehealth-based depression care using these medications.

Spravato (Esketamine): Special Requirements

Spravato is the only commonly prescribed depression medication subject to Delaware’s EPCS requirement. Because it is a Schedule III controlled substance, it must be electronically prescribed. However, EPCS is only one of several barriers for Spravato coverage under Humana MAPD:

• Treatment-resistant depression (TRD): HPS requires documentation of at least 2 adequate antidepressant trials that failed before Spravato will be considered for coverage
• REMS program: Spravato carries an FDA Risk Evaluation and Mitigation Strategy (REMS). It must be administered in a certified healthcare setting with 2 hours of post-dose monitoring. It cannot be dispensed for at-home use
• Specialty PA: Prior authorization required, including TRD documentation, REMS certification, and prescriber attestation
• EPCS REQUIRED: Electronic prescription mandatory under DE Admin Code Title 24 § 1700
• Pure telehealth not possible: Due to REMS in-office administration requirements, Spravato cannot be managed entirely via telehealth

For most patients with depression who are not in the Spravato pathway, telehealth prescribing through Klarity Health involves no EPCS barriers under Delaware law.

Prior Authorization for Depression Medications Under HPS

For most standard antidepressants on the HPS formulary, prior authorization is not typically required. The PA burden for depression medications under Humana MAPD is concentrated in step therapy and specialty tiers:

• Generic SSRIs/SNRIs/bupropion/mirtazapine: Typically covered at Tier 1. 2 with no PA required. Most common first-line agents are accessible without prior authorization.
• Trintellix (vortioxetine): Step therapy. HPS may require documentation of a prior SSRI or SNRI trial before approving Trintellix coverage
• Auvelity: PA required. Must demonstrate clinical rationale, often including prior antidepressant failure
• Spravato: Specialty PA required. TRD documentation (2+ failed trials), REMS enrollment confirmation, and prescriber attestation

5-Step Prior Authorization Process (HPS)

1. Prescriber submits PA request to HPS at 1-800-379-0092 with clinical documentation
2. HPS reviews against clinical criteria (within 72 hours for standard; 24 hours for urgent)
3. Decision issued. Approval, denial, or request for additional information
4. If denied: Request a peer-to-peer (P2P) review. Your clinician speaks directly with the HPS medical director within 48 hours
5. If P2P fails: File a formal redetermination (see appeal section below)

Federal Mental Health Parity Rights (MHPAEA) for Humana MAPD

Although § 3343 does not govern your Humana MAPD plan, federal MHPAEA protections do apply via CMS. Key parity rights for Humana MAPD members in Delaware:

1. Non-quantitative treatment limitations (NQTLs): Humana cannot apply PA, step therapy, or formulary restrictions to depression treatment that are more burdensome than those applied to comparable medical/surgical conditions without a clinical basis
2. Formulary parity: Depression medications must be placed on formulary tiers comparable to equivalent-cost medical drugs
3. Benefit parity: Mental health outpatient visit cost-sharing cannot exceed comparable medical outpatient visit cost-sharing
4. Network adequacy: CMS requires Humana to maintain adequate networks of mental health providers, including access to telehealth

If you believe Humana is applying a MHPAEA violation, file a complaint with CMS at 1-800-633-4227 or via medicare.gov. Do not file with the Delaware DOI. It does not have jurisdiction over MAPD plans for these purposes.

Telehealth Depression Treatment Under Humana MAPD in Delaware

Telehealth coverage for depression is generally strong under Humana Medicare Advantage in Delaware. CMS has permanently expanded many telehealth benefits for Medicare Advantage plans, and Humana covers most behavioral health telehealth services.

Key telehealth considerations for depression treatment:

• Standard antidepressants (SSRIs, SNRIs, bupropion, mirtazapine): No EPCS barrier under Delaware law. These can be prescribed via telehealth. No DEA controlled substance requirements apply.
• Trintellix and Auvelity: Non-scheduled. No EPCS barrier. Step therapy or PA documentation may be required before approval, but the prescribing itself has no telehealth restriction under Delaware law.
• Spravato: Cannot be managed purely via telehealth due to the REMS in-office administration requirement. However, evaluation and follow-up visits may be conducted via telehealth at certified REMS facilities that offer the service.
• Ryan Haight Act: The Ryan Haight Online Pharmacy Consumer Protection Act applies only to Schedule II-IV controlled substances. Standard antidepressants are non-scheduled and are not subject to Ryan Haight requirements. Spravato (Schedule III) carries Ryan Haight implications, but the REMS in-office requirement already makes remote prescribing impractical regardless.

Klarity Health’s 2,000+ licensed providers include psychiatrists and licensed clinicians who can evaluate, diagnose, and prescribe non-scheduled antidepressants via telehealth for eligible Humana MAPD members in Delaware.

Medicaid and Dual-Eligible Members

If you have both Humana Medicare Advantage and Delaware Medicaid (dual-eligible), your coverage may work differently:

• LIS / Extra Help: Low-Income Subsidy (Extra Help) is available to dual-eligible Medicare members. It can significantly reduce your Part D cost-sharing for depression medications, including monthly premiums, deductibles, and copays
• Humana D-SNP: Humana offers Dual-Eligible Special Needs Plans (D-SNPs) in some Delaware service areas. D-SNPs are specifically designed to coordinate Medicare and Medicaid benefits. Check if your specific plan is a D-SNP by calling Humana at 1-800-448-6262
• Delaware Medicaid (DMAP): Delaware Division of Medicaid and Medical Assistance manages state Medicaid. Contact DMAP at 1-800-372-2022 to verify Medicaid coordination
• Cost-sharing differences: D-SNP members often have $0 or very low cost-sharing for mental health services under both Medicare and Medicaid coordination
• Disclaimer: Medicaid rules change. Coverage verification should be confirmed directly with Humana and DMAP before beginning treatment

Federal Appeal Process for Humana MAPD Coverage Denials

If Humana denies coverage for a depression medication or service, the appeal process for Medicare Advantage plans is governed by CMS. Not Delaware state law. Delaware’s external review process does not apply to MAPD plans.

Important: Do not file an appeal with the Delaware DOI for MAPD coverage denials. The DOI has very limited jurisdiction over Medicare Advantage plans. Use the CMS Medicare appeal ladder above. For assistance, contact your Delaware SHIP (State Health Insurance Assistance Program) at 1-800-336-9500. SHIP counselors provide free guidance on Medicare appeals.

Humana vs. Other Delaware Insurers: Depression Coverage Comparison

The primary distinctions for Humana MAPD vs. commercial DE insurers on depression coverage are the governing framework (CMS vs. § 3343) and the appeal pathway (federal Medicare appeals vs. Delaware DOI external review). The clinical coverage landscape. Formulary tiers, PA patterns, EPCS rules. Is broadly similar.

5-Step Checklist: Verify Your Humana Depression Coverage in Delaware

1. Confirm your plan type: Call Humana at 1-800-448-6262 or log in to MyHumana to confirm you have a Medicare Advantage (MAPD) plan, not a commercial plan
2. Check the formulary: Use the HPS drug search tool or call 1-800-379-0092 to verify your specific antidepressant’s tier, PA requirements, and quantity limits
3. Verify EPCS applicability: For standard antidepressants (SSRIs, SNRIs, bupropion, mirtazapine, Trintellix, Auvelity). EPCS does not apply. For Spravato. EPCS is required, as is in-office administration under REMS
4. Check dual-eligible status: If you have Delaware Medicaid, ask Humana if you are enrolled in a D-SNP and whether LIS/Extra Help applies to your Part D cost-sharing
5. Understand the appeal pathway: If coverage is denied, initiate a Humana redetermination within 60 days. If denied, escalate to Maximus IRE at 1-855-887-6668. Contact Delaware SHIP (1-800-336-9500) for free assistance

Frequently Asked Questions

Does Humana cover antidepressants like Zoloft or Lexapro in Delaware?

Humana Medicare Advantage Part D plans administered by HPS typically cover generic SSRIs like sertraline (Zoloft) and escitalopram (Lexapro) at Tier 1 with no prior authorization required. Coverage amounts vary by plan. Verify your specific Evidence of Coverage.

Does Delaware’s mental health parity law (§ 3343) apply to my Humana plan?

No. Del. Code Ann. tit. 18, § 3343 applies to fully insured commercial plans, not Medicare Advantage plans. Your Humana MAPD plan is governed by CMS under 42 CFR Part 422 and by federal MHPAEA. Parity complaints go to CMS, not the Delaware DOI.

Can I get antidepressants prescribed via telehealth with Humana in Delaware?

Yes. Standard antidepressants (SSRIs, SNRIs, bupropion, mirtazapine, Trintellix, Auvelity) are non-scheduled under Delaware law. There are no EPCS barriers for telehealth prescribing of these medications. Humana MAPD generally covers telehealth behavioral health visits.

Does EPCS apply to my antidepressant in Delaware?

Only if you are prescribed Spravato (esketamine), which is a Schedule III controlled substance. All other commonly prescribed antidepressants are non-scheduled, and Delaware’s EPCS law does not apply to them.

What is the PA process for Spravato under Humana in Delaware?

Spravato requires specialty prior authorization from HPS, including documentation of treatment-resistant depression (at least 2 failed adequate antidepressant trials), REMS certification of the prescribing facility, and prescriber attestation. It also requires in-office administration with 2 hours of monitoring. Pure telehealth management is not possible.

What should I do if Humana denies my depression medication?

Request a Humana redetermination within 60 days of the denial. If denied again, escalate to Maximus IRE at 1-855-887-6668. Free assistance is available through Delaware SHIP at 1-800-336-9500. Do not file with the Delaware DOI. It has limited MAPD jurisdiction.

Get Help Verifying Your Humana Depression Coverage in Delaware

Klarity Health’s network of 2,000+ licensed providers can help you navigate Humana MAPD coverage for depression treatment in Delaware. Our clinicians are experienced with Medicare Advantage plans and can evaluate whether your treatment plan aligns with what HPS may cover.

Verify your benefits and see if you may qualify for depression treatment with Klarity Health

Key Contacts

• Humana Member Services: 1-800-448-6262
• Humana Pharmacy Solutions (HPS): 1-800-379-0092
• Delaware Department of Insurance: 1-302-674-7300
• Delaware SHIP (free Medicare counseling): 1-800-336-9500
• Delaware Medicaid (DMAP): 1-800-372-2022
• Maximus IRE (Medicare appeals): 1-855-887-6668
• CMS (Medicare): 1-800-633-4227

Disclaimer: Coverage information in this guide reflects general HPS and Humana MAPD policies as of 2026 and is subject to change. Coverage varies by specific plan and formulary. Always verify your benefits directly with Humana at 1-800-448-6262 or HPS at 1-800-379-0092 before beginning treatment. This guide does not constitute insurance or legal advice. Delaware state insurance law (§ 3343) does not apply to Medicare Advantage plans. Consult CMS or a SHIP counselor for MAPD-specific guidance.